{"nctId":"NCT02268305","briefTitle":"The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain","startDateStruct":{"date":"2015-02","type":"ACTUAL"},"conditions":["Low Back Pain"],"count":100,"armGroups":[{"label":"MSM 1000mg twice a day (6000 mgs)","type":"EXPERIMENTAL","interventionNames":["Drug: MSM 1000mg twice a day (6000 mgs)"]},{"label":"Placebo capsules twice a day","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo capsules twice a day"]}],"interventions":[{"name":"MSM 1000mg twice a day (6000 mgs)","otherNames":["Methylsulfonylmethane"]},{"name":"Placebo capsules twice a day","otherNames":["Placebo"]}],"eligibilityModule":{"eligibilityCriteria":"THIS STUDY IS BEING CONDUCTED AT A MILITARY INSTALLATION. YOU MUST HAVE MILITARY INSURANCE IN ORDER TO PARTICIPATE IN THIS STUDY.\n\nInclusion:\n\nDoD beneficiaries between the ages of 18-65 years old Symptoms of Low Back Pain greater than 12 weeks duration Patients with a history of lower back surgery may be included\n\nExclusion:\n\nDoD beneficiaries less than 18 years old or greater than 65 years old\n\nLower back pain caused by any of the following:\n\nInfection Tumor Osteoporosis Ankylosing spondylitis Fracture Deformity Inflammatory process Cauda equina syndrome Treated or untreated central nervous system impairment\n\nMeeting the criteria for surgery, including:\n\nprogressive motor deficit sphincter impairment from neurological cause disabling sciatic pain (in the absence of backache) lasting 6 weeks or more that is attributed to a compromised nerve root and demonstrated by magnetic resonance imaging or computed tomography Oncologic disease during the previous 5 years Unexplained weight loss, fever, or chills Diagnosed upper urinary tract infection within last 28 days Patients identified during standard of care interview to have a history of intravenous drug use.\n\nImmunocompromised host\n\nA severe comorbidity to include:\n\ndetermining overall well-being (e.g. painful disabling arthritic hip joints) Cirrhosis Ongoing dialysis Radiating symptoms to lower extremities (sciatica) History of bleeding disorders History of high blood pressure History of heart, kidney, liver or ulcer disease Allergic to analgesics or Non-steroidal anti inflammatory agents (NSAIDs) Pregnant or breastfeeding Initial pain rating of greater than 8/10 on initial intake evaluation If any of the components of the comprehensive metabolic panel are outside the Nellis clinical laboratory reference ranges, the subject will be excluded from the study\n\nIf any of these four components of the complete blood count are outside of the Nellis clinical laboratory reference ranges, the subject will be excluded from the study:\n\nWhite blood cell count Hemoglobin Hematocrit Platelets\n\nPatients taking any of the following medications are excluded from participating, unless they agree to wash out for two weeks prior to entering the study:\n\nMuscle relaxers of any type Non-steroidal anti-inflammatory agents (NSAIDs) \\* Patients taking naproxen must agree to wash out for two weeks prior to entering the study, but can begin taking it again, as prescribed, after Visit 1 where a baseline pain assessment is performed.\n\nTramadol Gabapentin Pregabalin Glucosamine Narcotic pain medications","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pain Level","description":"decrease in pain via analogue pain scale of 0-10 (with 10 being the worst pain)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"1.5"},{"groupId":"OG001","value":"3.7","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"1.5"},{"groupId":"OG001","value":"2.9","spread":"2.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"1.6"},{"groupId":"OG001","value":"3.1","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"1.4"},{"groupId":"OG001","value":"3.2","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"1.7"},{"groupId":"OG001","value":"3.4","spread":"2.4"}]}]}]},{"type":"SECONDARY","title":"Roland-Morris Disability Questionnaire","description":"symptoms of lower back pain. 0 (no disability) to 24 (max. disability).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":"4.2"},{"groupId":"OG001","value":"8.4","spread":"5.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"4.3"},{"groupId":"OG001","value":"6.9","spread":"5.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"3.9"},{"groupId":"OG001","value":"6.7","spread":"5.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.4","spread":"4.2"},{"groupId":"OG001","value":"6.9","spread":"4.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"4.4"},{"groupId":"OG001","value":"6.8","spread":"5.7"}]}]}]},{"type":"SECONDARY","title":"Pain Impact Questionnaire-6","description":"6-item questionnaire measuring pain's interference with life activities. The total possible score of the PIQ-6 ranges from 40-78 points, where lower scores indicate less pain interference.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.8","spread":"5.0"},{"groupId":"OG001","value":"60.2","spread":"6.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.4","spread":"6.5"},{"groupId":"OG001","value":"56.7","spread":"8.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.0","spread":"6.4"},{"groupId":"OG001","value":"57.2","spread":"9.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.5","spread":"6.4"},{"groupId":"OG001","value":"56.3","spread":"9.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57.0","spread":"6.9"},{"groupId":"OG001","value":"57.8","spread":"8.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["musculoskeletal pain","colitis"]}}}